379 related articles for article (PubMed ID: 10356112)
1. Neuroprotective FK506 does not alter in vivo nitric oxide production during ischemia and early reperfusion in rats.
Toung TJ; Bhardwaj A; Dawson VL; Dawson TM; Traystman RJ; Hurn PD
Stroke; 1999 Jun; 30(6):1279-85. PubMed ID: 10356112
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats.
Goyagi T; Toung TJ; Kirsch JR; Traystman RJ; Koehler RC; Hurn PD; Bhardwaj A
Stroke; 2003 Jun; 34(6):1533-8. PubMed ID: 12738895
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production.
Goyagi T; Goto S; Bhardwaj A; Dawson VL; Hurn PD; Kirsch JR
Stroke; 2001 Jul; 32(7):1613-20. PubMed ID: 11441209
[TBL] [Abstract][Full Text] [Related]
4. Prolonged opportunity for ischemic neuroprotection with selective kappa-opioid receptor agonist in rats.
Chen TY; Goyagi T; Toung TJ; Kirsch JR; Hurn PD; Koehler RC; Bhardwaj A
Stroke; 2004 May; 35(5):1180-5. PubMed ID: 15031456
[TBL] [Abstract][Full Text] [Related]
5. sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion.
Harukuni I; Bhardwaj A; Shaivitz AB; DeVries AC; London ED; Hurn PD; Traystman RJ; Kirsch JR; Faraci FM
Stroke; 2000 Apr; 31(4):976-82. PubMed ID: 10754008
[TBL] [Abstract][Full Text] [Related]
6. Ischemic neuroprotection with selective kappa-opioid receptor agonist is gender specific.
Chen CH; Toung TJ; Hurn PD; Koehler RC; Bhardwaj A
Stroke; 2005 Jul; 36(7):1557-61. PubMed ID: 15933260
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat: therapeutic time window for FK506 in transient focal ischemia.
Arii T; Kamiya T; Arii K; Ueda M; Nito C; Katsura KI; Katayama Y
Neurol Res; 2001 Oct; 23(7):755-60. PubMed ID: 11680517
[TBL] [Abstract][Full Text] [Related]
8. FK506 ameliorates oxidative damage and protects rat brain following transient focal cerebral ischemia.
Nito C; Ueda M; Inaba T; Katsura K; Katayama Y
Neurol Res; 2011 Oct; 33(8):881-9. PubMed ID: 22004713
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection from focal ischemia by 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is dependent on treatment duration in rats.
Harukuni I; Bhardwaj A; Traystman RJ; Crain B; London ED; Kirsch JR
Anesth Analg; 1998 Dec; 87(6):1299-305. PubMed ID: 9842816
[TBL] [Abstract][Full Text] [Related]
10. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats.
Nito C; Kamiya T; Ueda M; Arii T; Katayama Y
Brain Res; 2004 May; 1008(2):179-85. PubMed ID: 15145754
[TBL] [Abstract][Full Text] [Related]
11. Effect of AR-R 17477, a potent neuronal nitric oxide synthase inhibitor, on infarction volume resulting from permanent focal ischemia in rats.
Harukuni I; Traystman RJ; Kirsch JR
Crit Care Med; 1999 Nov; 27(11):2508-11. PubMed ID: 10579272
[TBL] [Abstract][Full Text] [Related]
12. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
Zawadzka M; Kaminska B
Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide synthase inhibition reduces caudate injury following transient focal ischemia in cats.
Nishikawa T; Kirsch JR; Koehler RC; Miyabe M; Traystman RJ
Stroke; 1994 Apr; 25(4):877-85. PubMed ID: 7512764
[TBL] [Abstract][Full Text] [Related]
14. Hypertonic saline worsens infarct volume after transient focal ischemia in rats.
Bhardwaj A; Harukuni I; Murphy SJ; Alkayed NJ; Crain BJ; Koehler RC; Hurn PD; Traystman RJ
Stroke; 2000 Jul; 31(7):1694-701. PubMed ID: 10884475
[TBL] [Abstract][Full Text] [Related]
15. Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase.
Buchan AM; Gertler SZ; Huang ZG; Li H; Chaundy KE; Xue D
Neuroscience; 1994 Jul; 61(1):1-11. PubMed ID: 7526264
[TBL] [Abstract][Full Text] [Related]
16. The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats.
Kuluz JW; Prado RJ; Dietrich WD; Schleien CL; Watson BD
Stroke; 1993 Dec; 24(12):2023-9. PubMed ID: 7504336
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the effects of two nitric oxide synthase inhibitors and two nitric oxide donors on temporary focal cerebral ischemia in the Wistar rat.
Coert BA; Anderson RE; Meyer FB
J Neurosurg; 1999 Feb; 90(2):332-8. PubMed ID: 9950505
[TBL] [Abstract][Full Text] [Related]
18. Potent sigma 1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats.
Goyagi T; Bhardwaj A; Koehler RC; Traystman RJ; Hurn PD; Kirsch JR
Anesth Analg; 2003 Feb; 96(2):532-8, table of contents. PubMed ID: 12538208
[TBL] [Abstract][Full Text] [Related]
19. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent.
Kapinya KJ; Löwl D; Fütterer C; Maurer M; Waschke KF; Isaev NK; Dirnagl U
Stroke; 2002 Jul; 33(7):1889-98. PubMed ID: 12105371
[TBL] [Abstract][Full Text] [Related]
20. Potent sigma1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo.
Bhardwaj A; Sawada M; London ED; Koehler RC; Traystman RJ; Kirsch JR
Stroke; 1998 Nov; 29(11):2404-10; discussion 2411. PubMed ID: 9804655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
